OTLK icon

Outlook Therapeutics

14 hedge funds and large institutions have $1.54M invested in Outlook Therapeutics in 2019 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 0 increasing their positions, 6 reducing their positions, and 6 closing their positions.

Holders
14
Holders Change
+2
Holders Change %
+16.67%
% of All Funds
0.3%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
8
Increased
Reduced
6
Closed
6
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
ACA
1
Avoro Capital Advisors
New York
$630K 84,999 -595,001 -88%
Vanguard Group
2
Vanguard Group
Pennsylvania
$361K 48,763 -340,036 -87%
UCFA
3
United Capital Financial Advisors
Texas
$293K 39,625 +39,625 New
Renaissance Technologies
4
Renaissance Technologies
New York
$83K 11,166 +11,166 New
Deutsche Bank
5
Deutsche Bank
Germany
$82K 11,166 +11,166 New
PAM
6
Panagora Asset Management
Massachusetts
$39K 5,276 -55,611 -91%
Bank of America
7
Bank of America
North Carolina
$10K 1,287 -9,011 -88%
Morgan Stanley
8
Morgan Stanley
New York
$9K 1,212 -8,488 -88%
PWMG
9
Prestige Wealth Management Group
New Jersey
$9K 1,250 +1,250 New
RIA
10
Realta Investment Advisors
Delaware
$9K 1,250 +1,250 New
AG
11
Advisor Group
Arizona
$5K 625 +625 New
LTFS
12
Ladenburg Thalmann Financial Services
Florida
$4K 500 +500 New
UBS Group
13
UBS Group
Switzerland
$1K 187 -1,313 -88%
SM
14
Sabby Management
Florida
-2,786,448 Closed
MWNA
15
Marshall Wace North America
New York
-199,313 Closed
Susquehanna International Group
16
Susquehanna International Group
Pennsylvania
-113,927 Closed
ACP
17
Acuta Capital Partners
California
-29,082 Closed
MFGP
18
Marshall Financial Group (Pennsylvania)
Pennsylvania
-15,000 Closed
Geode Capital Management
19
Geode Capital Management
Massachusetts
-11,165 Closed
CFGS
20
Concourse Financial Group Securities
Alabama
Barclays
21
Barclays
United Kingdom
$0 19 +19 New